TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $59.63 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $59.63, a 22.09% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $48.84, a 30.00% increase from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $37.57, a 8.94% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $41.26, a 2.69% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $59.63 10-K · filed 2026-02-03 |
| 2024-12-31 | $48.84 10-K · filed 2026-02-03 |
| 2023-12-31 | $37.57 10-K · filed 2026-02-03 |
| 2022-12-31 | $41.26 10-K · filed 2025-02-05 |
| 2021-12-31 | $42.40 10-K · filed 2024-02-12 |
| 2020-12-31 | $49.35 10-K · filed 2023-02-10 |
| 2018-12-31 | $50.65 10-K · filed 2021-02-10 |
| 2017-12-31 | $59.81 10-K · filed 2020-02-21 |
| 2016-12-31 | $52.79 10-K · filed 2019-02-19 |